ALYSSA CHRISTOFAS: Open Payments
NPI 1083387799 · SOUTHAMPTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 20 payments from 13 companies in 2025. Trend: 2023 $366 · 2024 $892 · 2025 $1,254
Food & beverage: $1,254
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $289 |
| Alnylam Pharmaceuticals Inc. | 2 | $264 |
| Travere Therapeutics, Inc. | 1 | $138 |
| Merck Sharp & Dohme LLC | 2 | $134 |
| Gilead Sciences, Inc. | 1 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $108 |
| Cipher Pharmaceuticals US LLC | 1 | $55 |
| Daiichi Sankyo Inc. | 2 | $52 |
| Janssen Biotech, Inc. | 1 | $30 |
| BeOne Medicines USA, Inc. | 1 | $25 |
Products named: ONPATTRO, Filspari, BREZTRI, ZERBAXA, FASENRA, Yeztugo, CAPLYTA, Natroba.
Industry payments across PA — which companies pay providers there.
